Robust global surveillance from the World Health Organization and Centers for Disease Control and Prevention shows no novel pathogen with sustained human-to-human transmission capable of triggering a 2026 pandemic, supporting the 89.5% market-implied odds against a new outbreak. Current confirmed case data for monitored threats, including avian influenza H5N1 and Oropouche virus, remain limited to sporadic zoonotic spillovers without evidence of efficient person-to-person spread or epidemic growth. Ongoing low global SARS-CoV-2 activity and contained clusters of other respiratory viruses align with historical patterns where pandemics emerge infrequently. Recent April 2026 WHO simulation exercises and updated epidemiological assessments reinforce preparedness without signaling imminent escalation, though evolving viral mutations or surveillance gaps could still alter trajectories before year-end.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoSí
$406,525 Vol.
$406,525 Vol.
Sí
$406,525 Vol.
$406,525 Vol.
The resolution source will be official announcements from the World Health Organization.
Mercado abierto: Dec 1, 2025, 4:37 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...Robust global surveillance from the World Health Organization and Centers for Disease Control and Prevention shows no novel pathogen with sustained human-to-human transmission capable of triggering a 2026 pandemic, supporting the 89.5% market-implied odds against a new outbreak. Current confirmed case data for monitored threats, including avian influenza H5N1 and Oropouche virus, remain limited to sporadic zoonotic spillovers without evidence of efficient person-to-person spread or epidemic growth. Ongoing low global SARS-CoV-2 activity and contained clusters of other respiratory viruses align with historical patterns where pandemics emerge infrequently. Recent April 2026 WHO simulation exercises and updated epidemiological assessments reinforce preparedness without signaling imminent escalation, though evolving viral mutations or surveillance gaps could still alter trajectories before year-end.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes